Steven Cohen's OMDA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 597,997 shares of Omada Health, Inc. (OMDA) worth $13.13 M, representing 0.01% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in OMDA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 341,070 shares. Largest reduction occurred in Q2 2026, reducing 308,210 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Omada Health (OMDA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Omada Health (OMDA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -308,210 | Reduce 34.01% | 597,997 | $21.95 |
| Q1 2026 | +109,477 | Add 13.74% | 906,207 | $12.57 |
| Q4 2025 | -219,839 | Reduce 21.63% | 796,730 | $15.78 |
| Q3 2025 | +341,070 | Add 50.49% | 1.02 M | $22.11 |
| Q2 2025 | +675,499 | New Buy | 675,499 | $18.30 |
Steven Cohen's Omada Health Investment FAQs
Steven Cohen first purchased Omada Health, Inc. (OMDA) in Q2 2025, acquiring 675,499 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Omada Health, Inc. (OMDA) for 5 quarters since Q2 2025.
Steven Cohen's largest addition to Omada Health, Inc. (OMDA) was in Q2 2025, adding 675,499 shares worth $12.36 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 597,997 shares of Omada Health, Inc. (OMDA), valued at approximately $13.13 M.
As of the Q2 2026 filing, Omada Health, Inc. (OMDA) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Omada Health, Inc. (OMDA) was 1,016,569 shares, as reported at the end of Q3 2025.